Lexeo Therapeutics, Inc. (LXEO) has 39 open-market insider trades by 10 insiders since 2023. Over the last six months insiders net sold $323K. The most active filer is Richard Nolan Townsend, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Anne-Mari Paster | 10% Owner | — | 1 | $5.0M | 2023-11-07 |
| Invest A/s Lundbeckfond | 10% Owner | — | 1 | $2.5M | 2023-11-07 |
| Richard Nolan Townsend | CEO | — | 10 | $499K | 2026-09-14 |
| Paula H. Cholmondeley | Dir | — | 1 | $105K | 2024-11-25 |
| Jose Manuel Otero | COO | — | 8 | $99K | 2026-09-14 |
| Narinder Pal Bhalla | — | — | 1 | $99K | 2026-09-14 |
| Eric Adler | Chief Medical Officer | — | 5 | $51K | 2025-11-18 |
| Jenny Robertson | CLO | — | 5 | $50K | 2025-11-18 |
| Tai Sandi See | Chief Development Officer | — | 5 | $48K | 2025-11-18 |
| Louis Edward Tamayo | CFO | — | 2 | $41K | 2026-08-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Richard Nolan Townsend | CEO | Sell | $17K | 2026-08-18 |
| Louis Edward Tamayo | CFO | Sell | $20K | 2026-08-18 |
| Jose Manuel Otero | COO | Sell | $6K | 2026-08-18 |
| Richard Nolan Townsend | CEO | Sell | $116K | 2026-07-01 |
| Louis Edward Tamayo | CFO | Sell | $21K | 2026-07-01 |
| Jose Manuel Otero | COO | Sell | $21K | 2026-07-01 |
Companies that share insiders with LXEO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Narinder Pal Bhalla | — | Sell | $99K | 2026-07-01 |
| Richard Nolan Townsend | CEO | Sell | $17K | 2026-05-18 |
| Jose Manuel Otero | COO | Sell | $7K | 2026-05-18 |
| Richard Nolan Townsend | CEO | Sell | $313K | 2026-04-06 |
| Jose Manuel Otero | COO | Sell | $19K | 2026-02-18 |
| Richard Nolan Townsend | CEO | Sell | $65K | 2026-02-18 |
| Richard Nolan Townsend | CEO | Sell | $10K | 2025-11-18 |
| Jose Manuel Otero | COO | Sell | $7K | 2025-11-18 |
| Tai Sandi See | Chief Development Officer | Sell | $4K | 2025-11-18 |